432 items to be re-evaluated for bioequivalence

Published: 2011-01-05 06:57:00
Updated: 2011-01-05 06:57:00
The Korea food and Drug Administration announced on January 3 that a total of 432 drugs (23 active pharmaceutical ingredients), including combination drugs, will be re-evaluated for bioequivalence.

By combined active substance, the bioequivalence re-assessment program will cover glibenclamide/...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.